Cookies on our website

We use cookies on our website. To learn more about cookies, how we use them on our site and how to change your cookie settings please view our cookie policy.

Read more Close
Skip Ribbon Commands
Skip to main content
You searched for:
Search

Search

Practice
 
Sub-Practice
 
Sector
 
Sub-Sector
 
Country
 
Language
 
21-30 of 119 results
Results per page: 
Sort by: 
As governments around the world grapple with an estimated USD71 trillion bill for new infrastructure between now and 2030, Allen & Overy has today launched a Global Guide to PPP highlighting the key issues for the growing number of governments using As governments around the world grapple with an
09 May 2012
http://www.allenovery.com/publications/en-g … de-to-Public-Private-Partnerships-(PPP).aspx
U.S. and EU impose further sanctions in relation to actions in Ukraine - Update U.S. and EU impose further sanctions in relation to actions in Ukraine - Update
19 May 2014
http://www.allenovery.com/publications/en-g … relation-to-actions-in-Ukraine---Update.aspx
Outsourcing: A Data and Financial Regulation Perspective - Free Webinar Outsourcing: A Data and Financial Regulation Perspective - Free Webinar
06 May 2014
http://www.allenovery.com/publications/en-g … l-Regulation-Perspective---Free-Webinar.aspx
Allen & Overy has been recognised as the “Law Firm of the Year” at the annual IJGlobal Asia Pacific Awards ceremony held in Singapore last night.
25 March 2015
http://www.allenovery.com/news/en-gb/articl … obals-Asia-Pacific-Law-Firm-of-the-Year.aspx
M&A Index Q4 2013 M&A Index Q4 2013
13 January 2014
http://www.allenovery.com/publications/en-gb/Pages/M-A-Index-Q4-2013.aspx
Shareholding Disclosure Free Webinar Shareholding Disclosure Free Webinar
27 February 2014
http://www.allenovery.com/publications/en-g … es/Shareholding-Disclosure-Free-Webinar.aspx
M&A Index Q3 2013 M&A Index Q3 2013
06 November 2013
http://www.allenovery.com/publications/en-gb/Pages/M-A-Index-Q3-2013.aspx
Transparency of clinical trials data Transparency of clinical trials data
28 May 2013
http://www.allenovery.com/publications/en-g … es/Transparency-of-clinical-trials-data.aspx
Regulators are faced with a choice. They can engage with senior management of banks or they can draw the battle lines with them. It will be unfortunate if they choose confrontation as there are many within the industry that have a great deal to contr Regulators are faced with a choice. They can
20 March 2009
http://www.allenovery.com/publications/en-g … eed-constructive-debate,-not-scapegoats.aspx
M&A Index H1 2013 M&A Index H1 2013
19 July 2013
http://www.allenovery.com/publications/en-gb/Pages/M-A-Index-H1-2013.aspx


  • Add comment (optional)